Research has already suggested a link between oral health and inflammatory diseases, in particular, heart attacks and strokes.
The results from a trial of a plaque identifying toothpaste (Plaque HD), show statistically significant reductions in dental plaque and inflammation throughout the body. Inflammation in the body is accurately measured by high sensitivity C-reactive protein (hs-CRP), a sensitive marker for future heart attacks and strokes. These results, published in the American Journal of Medicine, show that the toothpaste produced statistically significant reductions in dental plaque and inflammation throughout the body.
In this trial, all randomised subjects were given the same brushing protocol and received a 60-day supply of toothpaste containing either Plaque HD or an identical non-plaque identifying placebo.
“While the findings on reducing dental plaque extend a previous observation, the findings on decreasing inflammation are new and novel,” said Dr Charles H. Hennekens, senior author on the study.
Dr Joseph S. Alpert, a cardiologist, noted the importance and timeliness of these findings and commented on how his father, a dentist, had told him even before he went to medical school, that dental health may affect heart attacks and strokes.
Plaque HD reveals plaque so that it can be removed with directed brushing. In addition, the product’s proprietary formulation contains combinations and concentrations of cleaning agents that weaken the core of the plaque structure to help the subject see and more effectively remove the plaque.